Global DNA Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for DNA Diagnostics Market is presumed to reach the market size of nearly USD 16.93 BN by 2030 from USD 11.21 BN in 2022 with a CAGR of 5.29% under the study period 2023 - 2030.

DNA diagnostics, also known as genetic testing or DNA testing, is a set of laboratory techniques and procedures used to analyze an individual's DNA (deoxyribonucleic acid) to gain information about their genetic makeup, genetic predispositions, ancestry, and potential genetic disorders or conditions. It provides valuable insights into an individual's genetic composition, helping healthcare professionals make informed decisions about disease diagnosis, risk assessment, and treatment.

MARKET DYNAMICS:

Advancements in genomic research have deepened the understanding of genetic links to diseases and conditions, spurring the demand for DNA diagnostics to assess genetic predispositions and personalize healthcare. This surge in awareness among individuals about genetic testing's potential benefits for health risk assessment, ancestry tracing, and personalized medicine has significantly boosted demand. The concept of precision medicine, which customizes healthcare interventions based on individual genetic profiles, relies heavily on DNA diagnostics. Additionally, the rising prevalence of cancer and the integration of genetic information in cancer treatment decisions have fueled the market, with genetic testing being used to identify mutations and guide therapy. Pharmacogenomics, prenatal and newborn screening, direct-to-consumer testing, regulatory support, and advancements in technology have all contributed to the market's growth. Furthermore, targeted therapies, healthcare personalization, and research investments by biotech and pharmaceutical companies are expanding the utility of DNA diagnostics. As the aging population and the trend toward personalized healthcare persist, the DNA diagnostics market is expected to continue evolving, offering a wider range of tests and applications. However, ethical and privacy concerns surrounding genetic data will remain a significant aspect of the market's development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dna diagnostics. The growth and trends of dna diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the dna diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Microarrays-Based Diagnostics
PCR-Based Diagnostics
In-Situ Hybridization Diagnostics
NGS DNA Diagnosis

By Application

Cancer Genetics Tests
Infectious Diseases Dna Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others)
Newborn Genetic Screening
Preimplantation & Reproductive Diagnosis
Non-Infectious Diseases Dna Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases)
Prenatal DNA Carrier Screening
Pharmacogenomics/Drug Metabolism
Hematology & Immunology/Identity Diagnostics & Forensics
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the DNA Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the DNA Diagnostics market include GE Healthcare, Abbott, Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Illumina Inc., Cepheid, Hologic Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche, QIAGEN, Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112254

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DNA DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

5.1 Overview by Technology
5.2 Historical and Forecast Data
5.3 Analysis by Technology
5.4 Microarrays-based Diagnostics Historic and Forecast Sales by Regions
5.5 PCR-based Diagnostics Historic and Forecast Sales by Regions
5.6 In-situ Hybridization Diagnostics Historic and Forecast Sales by Regions
5.7 NGS DNA Diagnosis Historic and Forecast Sales by Regions

6 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Cancer Genetics Tests Historic and Forecast Sales by Regions
6.5 Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Historic and Forecast Sales by Regions
6.6 Newborn Genetic Screening Historic and Forecast Sales by Regions
6.7 Preimplantation & Reproductive Diagnosis Historic and Forecast Sales by Regions
6.8 Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Historic and Forecast Sales by Regions
6.9 Prenatal DNA Carrier Screening Historic and Forecast Sales by Regions
6.10. Pharmacogenomics/Drug Metabolism Historic and Forecast Sales by Regions
6.11 Hematology & Immunology/Identity Diagnostics & Forensics Historic and Forecast Sales by Regions
6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DNA DIAGNOSTICS COMPANIES

8.1. Dna Diagnostics Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF DNA DIAGNOSTICS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. GE Healthcare
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Abbott
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Beckman Coulter Inc.
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Bio-Rad Laboratories Inc.
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Thermo Fisher Scientific Inc.
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Illumina Inc.
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Cepheid
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Hologic Inc.
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. Siemens Healthcare GmbH
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments
9.12. F. Hoffmann-La Roche
- 9.12.1. Company Overview
- 9.12.2. Company Revenue
- 9.12.3. Products
- 9.12.4. Recent Developments
9.13. QIAGEN
- 9.13.1. Company Overview
- 9.13.2. Company Revenue
- 9.13.3. Products
- 9.13.4. Recent Developments
9.14. Agilent Technologies Inc.
- 9.14.1. Company Overview
- 9.14.2. Company Revenue
- 9.14.3. Products
- 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies